141 related articles for article (PubMed ID: 2388047)
1. Hepatitis D virus infection among intravenous drug abusers in Taiwan: analysis of risk factors and liver function tests.
Hsu HM; Wang YF; Lo SH; Sun HC; Yip KK; Chen JS; Chuang CH; Chen DS
J Med Virol; 1990 Jun; 31(2):76-81. PubMed ID: 2388047
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B and D virus infection among drug abusers in Taiwan.
Lee SD; Wang JY; Wu JC; Chiang YT; Tsai YT; Lo KJ
J Med Virol; 1986 Nov; 20(3):247-52. PubMed ID: 3783132
[TBL] [Abstract][Full Text] [Related]
3. Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan.
Chung DC; Ko YC; Chen CJ; Chen ER; Wu CC; Wu PS
J Med Virol; 1989 Aug; 28(4):215-8. PubMed ID: 2778445
[TBL] [Abstract][Full Text] [Related]
4. Current seroepidemiology of hepatitis D virus infection among hepatitis B surface antigen carriers of general and high-risk populations in Taiwan.
Chen CJ; Tseng SF; Lu CF; Lin HC; You SL; Chen CS; Hwang SJ; Hsieh SF; Hsu ST
J Med Virol; 1992 Oct; 38(2):97-101. PubMed ID: 1460460
[TBL] [Abstract][Full Text] [Related]
5. Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan.
Lu MY; Chen CT; Shih YL; Tsai PC; Hsieh MH; Huang CF; Yeh ML; Huang CI; Wang SC; Tsai YS; Ko YM; Lin CC; Chen KY; Wei YJ; Hsu PY; Hsu CT; Jang TY; Liu TW; Liang PC; Hsieh MY; Lin ZY; Chen SC; Huang JF; Dai CY; Chuang WL; Yu ML; Chang WY
Sci Rep; 2021 Apr; 11(1):8554. PubMed ID: 33879825
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan.
Hsieh MH; Wang SC; Hsieh MY; Huang CF; Yeh ML; Yang JF; Chang K; Lin WR; Lin CY; Chen TC; Huang JF; Dai CY; Tsai JJ; Chuang WL; Yu ML
Kaohsiung J Med Sci; 2016 Oct; 32(10):526-530. PubMed ID: 27742037
[TBL] [Abstract][Full Text] [Related]
7. Seroepidemiological studies on hepatitis B and D viruses infection among five ethnic groups in southern Taiwan.
Chung DC; Ko YC; Chen CJ; Wu CC; Chen ER; Liaw YF; Hwang SJ
J Med Virol; 1988 Dec; 26(4):411-8. PubMed ID: 3209993
[TBL] [Abstract][Full Text] [Related]
8. [Seroprevalence of delta virus and hepatitis C virus in patients with chronic infection with hepatitis B virus].
de Miguel J; Collazos J; Mayo J; López de Goicoechea MJ; Echániz C; Mendarte U
Rev Clin Esp; 1994 Oct; 194(10):897-900. PubMed ID: 7800870
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan.
Chu FY; Chiang SC; Su FH; Chang YY; Cheng SH
J Med Virol; 2009 Jun; 81(6):973-8. PubMed ID: 19382252
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis D virus genotypes in intravenous drug users in taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes.
Kao JH; Chen PJ; Lai MY; Chen DS
J Clin Microbiol; 2002 Aug; 40(8):3047-9. PubMed ID: 12149376
[TBL] [Abstract][Full Text] [Related]
11. Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: a regression analysis of indicators of risk.
Craxì A; Tinè F; Vinci M; Almasio P; Cammà C; Garofalo G; Pagliaro L
Am J Epidemiol; 1991 Sep; 134(6):641-50. PubMed ID: 1951268
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
[TBL] [Abstract][Full Text] [Related]
13. The effect of HIV disease on serum markers of hepatitis delta infection in intravenous drug abusers.
Lake-Bakaar G; Bhat K; Govindarajan S
J Lab Clin Med; 1994 Oct; 124(4):564-8. PubMed ID: 7930880
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis delta virus infection in Taiwan.
Liaw YF; Lin HH; Chu CM; Sheen IS; Huang MJ
Prog Clin Biol Res; 1987; 234():479-83. PubMed ID: 3628418
[TBL] [Abstract][Full Text] [Related]
15. Contrasting prevalence of delta hepatitis markers in parenteral drug abusers with and without AIDS.
Kreek MJ; Des Jarlais DC; Trepo CL; Novick DM; Abdul-Quader A; Raghunath J
J Infect Dis; 1990 Aug; 162(2):538-41. PubMed ID: 2373877
[TBL] [Abstract][Full Text] [Related]
16. Correlation of hepatitis B virus, hepatitis D virus and human immunodeficiency virus type I infection markers in hepatitis B surface antigen positive haemophiliacs and patients without haemophilia with clinical and histopathological outcome of hepatitis.
Wagner N; Rotthauwe HW; Becker M; Dienes HP; Mertens T; Födisch HJ; Brackmann HH
Eur J Pediatr; 1992 Feb; 151(2):90-4. PubMed ID: 1537369
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B and delta virus infection among "at risk" populations in south east London.
Smith HM; Alexander GJ; Webb G; McManus T; McFarlane IG; Williams R
J Epidemiol Community Health; 1992 Apr; 46(2):144-7. PubMed ID: 1583429
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis D virus superinfection remains a rare occurrence in non-drug abusers in Hong Kong.
Lok AS; Wong A; Sporton S; Lai CL; Liu V; Chung HT
J Hepatol; 1992 Mar; 14(2-3):332-4. PubMed ID: 1500697
[TBL] [Abstract][Full Text] [Related]
19. Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program.
Lin HH; Lee SS; Yu ML; Chang TT; Su CW; Hu BS; Chen YS; Huang CK; Lai CH; Lin JN; Wu JC
Hepatology; 2015 Jun; 61(6):1870-9. PubMed ID: 25677884
[TBL] [Abstract][Full Text] [Related]
20. Sexual behaviour and multiple infections in drug abusers.
Coppola RC; Masia G; di Martino ML; Carboni G; Muggianu E; Piro R; Manconi PE
Eur J Epidemiol; 1996 Oct; 12(5):429-35. PubMed ID: 8905301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
